A Study in Adults With Grass Pollen-induced Rhinoconjunctivitis

Summary

This is a 2 year clinical study to compare 5-grass mix SLIT-drops with placebo in relieving grass pollen-induced rhinoconjunctivitis symptoms and in use of symptom-relieving medication during the second grass pollen season (peak grass pollen season, PGPS) The study will collect health-related quality of life data in the groups treated with 5-grass mix SLIT-drops or with placebo during the first and second PGPS. The trial medication used is already approved to treat allergic rhinitis caused by grass pollen in adults in several countries.

Timeline

Start

2021-05-10

Primary completion

2023-09-26

Completion

2023-09-26

Outcome

Met primary endpoint

registry Placebo vs 5-grass Mix SLIT-drops; p = 0.0036; Mean Difference (Final Values) 1.88 (95% CI 0.60 to 3.17) NCT04881461 ↗

Drugs

Indications